AstraZeneca Deepens China Cell Therapy Push - Quiz - MDSpire

AstraZeneca Deepens China Cell Therapy Push

New Shanghai manufacturing base and innovation center will support CAR-T production and a broader UK-China life sciences collaboration

March 31, 2026
2 min

The Medicine Maker

Share

Original Source(s)

The Medicine Maker

AstraZeneca Deepens China Cell Therapy Push

March 31, 2026

Related Content

Frontiers In Immunology

Exploring the Therapeutic Promise of γδ T Cells in Blood Disorders: Bridging Immunobiology and Clinical Innovation

by Xiaokuan Zhou, Mengqi Zhai, Zhe Zhang, Guojun Zhang
April 24, 2026

Bone Marrow Transplantation

Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myeloma

Frontiers In Oncology

Assessment of the Safety and Effectiveness of CD38-Targeted CAR-T Cell Therapy in Treating Multiple Myeloma: A Systematic Review and Meta-Analysis

by Xinlong Xu, Chang Dong, Jiashuo Guo, Xiaolin Chang, Yu Zhang, Shuting Gou, Liying Xue, Jie Li
April 29, 2026